Search

Research jobs in the Dauer lab.

Our lab has many ongoing HFpEF clinical trials, ranging from single-center, investigator-initiated research to large scale, multicenter trials. We investigate strategies to improve outcomes for patients with HFpEF, including novel pharmacotherapeutics, medical devices, and exercise rehabilitation.

Publications for Dr. Emina Huang's Lab

Skip to main content Big Data, Risk Prediction and Epidemiology Our lab uses big-data approaches to predict risk of heart failure that can be used to identify who may benefit from effective preventive therapies. We have also developed novel risk-prediction models to better predict risk of cardiovascu…

The Greenberg lab is focused on the development of novel therapeutic approaches to combat infectious diseases. For specific projects, please click on the links to the left.

Our lab has ongoing research within cardiovascular disease registries and administrative claims databases such as the AHA-Get With The Guidelines-Heart Failure program and CMS Medicare data, to study the impact of care provided during in-hospital and outpatient clinical encounters on long-term outcomes among patients with cardiovascular diseases such as heart failure.

Our lab has investigated the strengths and limitations of current biomarkers for risk prediction and cardiovascular screening.

Skip to main content Lab Fun Dallas Dr. Sam Pappas and Dr. Bill Dauer celebrate with Caitlin Leedy after her successful dissertation defense. Caitlin Leedy and Dr. Bill Dauer celebrate Caitlin's dissertation defense. The lab celebrates Lauren Miterko's next step in her career–Assistant Professor at A…

Our research focuses on developing and translating computational neuroimaging methods to delineate human brain structure-function relationships. Current applications include identifying biomarkers of disease progression and treatment response in multiple sclerosis and other neurodegenerative diseases. 

Active and Inactive Grants for the Cardiometabolic Research Unit